Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ral-binding protein 1 (RalBP1) is a putative effector protein of Ral and exhibits a GTPase activating activity for Rac and CDC42. To clarify the function of RalBP1, we isolated a novel protein that interacts with RalBP1 by yeast two-hybrid screening and designated it
POB1
(partner of RalBP1).
POB1
consists of 521 amino acids, shares a homology with Eps15, which has been identified as an
epidermal growth factor (EGF) receptor
substrate, and has two proline-rich motifs. The
POB1
mRNA was expressed in cerebrum, cerebellum, lung, kidney, and testis.
POB1
interacted with RalBP1 in COS cells and the C-terminal region of
POB1
was responsible for this interaction. The binding domain of RalBP1 to
POB1
was distinct from its binding domain to Ral. Ral and
POB1
simultaneously interacted with RalBP1 in COS cells. The binding of
POB1
to RalBP1 did not affect the GTPase activating activity of RalBP1. Furthermore,
POB1
bound to Grb2 but not to Nck or Crk.
POB1
was tyrosine-phosphorylated in COS cells upon stimulation with EGF and made a complex with EGF receptor. These results suggest that RalBP1 makes a complex with
POB1
and that this complex may provide a link between tyrosine kinase, Src homology 3 (SH3)-containing protein, and Ral.
...
PMID:Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. 942 36